Differentiating NSCLC from PTB remains a clinical challenge, especially when new or enlarging lung lesions appear during tuberculosis treatment.
This often leads to missed surgical opportunities and delays in cancer management.
Accurately identifying NSCLC within the context of PTB is essential for timely intervention.
